Calciphylaxis in Patients with Chronic Kidney Disease Case Presentation and Review
- 1 Nephrology Unit, Hospital De Clinicas, Buenos Aires, Argentina
- 2 Departmentof Medicine, Manizales University, Manizales, Colombia
- 3 Departmentof Medicine, Cooperativa University, Ibague, Colombia
- 4 Hematology Unit, Fluminense University, Rio de Janeiro, Brazil
- 5 Departmentof Medicine, Manizales University, Manizales, Colombia
- 6 Departmentof Medicine, Manizales University, Manizales, Colombia
- 7 Nephrology Unit, Fresenius Medical Care, Ibague, Colombia
- 8 Nephrology Unit, Hospital De Clinicas, Buenos Aires, Argentina
- 9 Nephrology Unit, Hospital De Clinicas, Buenos Aires, Argentina
- 10 Nephrology Unit, Hospital De Clinicas, Buenos Aires, Argentina
Abstract
Calciphylaxis is a serious disorder that presents itself as ischemia and ne-crosis of the skin which occurs more frequently in patients with an end-stage chronic kidney disease, but not exclusively. The pathogenesis is a result of the reduction of arteriolar blood flow, caused by calcification, fibrosis, and thrombus formation that primarily involve the arterioles of the dermis and hypodermis, with a poor prognosis. Case presentation: A 44-year-old patient with a previous diagnosis of chronic kidney disease receiving hemodialysis secondary to polycystic kidney disease, with a history of parathyroidectomy due to primary hyperparathyroidism in 2011. In 2014 the patient presented skin lesions, for which a diagnostic biopsy of calciphylaxis was performed and began treatment with sodium thiosulfate with a poor progression and evolution. New histology compatible with the diagnosis of pyoderma gangrenosum and findings of calciphylaxis were performed. The patient begins treatment with corticosteroids and cyclosporine, with poor clinical evolution and the patient eventually passes away. The objective of this manuscript is to understand this pathology better, which is infrequent but with a high rate of morbidity and mortality.
- Brandenburg, V.M., Cozzolino, M. and Mazzaferro, S. (2014) Calcific Uremic Arteriolopathy: A Call for Action. Seminars in Nephrology, 34, 641-647. https://doi.org/10.1016/j.semnephrol.2014.09.007
- Nigwekar, S.U. (2015) Multidisciplinary Approach to Calcific Uremic Arteriolopathy. Current Opinion in Nephrology Hypertension, 24, 531-537. https://doi.org/10.1097/MNH.0000000000000175
- Brandenburg, V.M., Kramann, R., Specht, P. and Ketteler, M. (2012) Calciphylaxis in CKD and beyond. Nephrology Dialysis Transplantation, 27, 1314-1318. https://doi.org/10.1093/ndt/gfs015
- Allegretti, A.S., Nazarian, R.M., Goverman, J. and Nigwekar, S.U. (2014) Calciphylaxis: A Rare but Fatal Delayed Complication of Roux-En-Y Gastric Bypass Surgery. American Journal of Kidney Diseases, 64, 274-277. https://doi.org/10.1053/j.ajkd.2014.02.029
- Nigwekar, S.U., Zhao, S., Wenger, J., et al. (2016) A Nationally Representative Study of Calcific Uremic Arteriolopathy Risk Factors. Journal of the American Society of Nephrology, 27, 3421-3429. https://doi.org/10.1681/ASN.2015091065
- Fine, A. and Zacharias, J. (2002) Calciphylaxis Is usually Non-Ulcerating: Risk Factors, Outcome and Therapy. Kidney International, 61, 2210-2217. https://doi.org/10.1046/j.1523-1755.2002.00375.x
- Bajaj, R., Courbebaisse, M., Kroshinsky, D., Thadhani, R.I. and Nigwekar, S.U. (2018) Calciphylaxis in Patients with Normal Renal Function: A Case Series and Systematic Review. Mayo Clinic Proceedings, 93, 1202-1212. https://doi.org/10.1016/j.mayocp.2018.06.001
- Nigwekar, S.U., Wolf, M., Sterns, R.H. and Hix, J.K. (2008) Calciphylaxis from Non-Uremic Causes: A Systematic Review. Clinical Journal of the American Society of Nephrology, 3, 1139-1143. https://doi.org/10.2215/CJN.00530108
- Weenig, R.H., Sewell, L.D., Davis, M.D., McCarthy, J.T. and Pittelkow, M.R. (2007) Calciphylaxis: Natural History, Risk Factor Analysis, and Outcome. Journal of the American Academy of Dermatology, 56, 569-579. https://doi.org/10.1016/j.jaad.2006.08.065
- Mazhar, A.R., Johnson, R.J., Gillen, D., Stivelman, J.C., Ryan, M.J., Davis, C.L., et al. (2001) Risk Factors and Mortality Associated with Calciphylaxis in End-Stage Renal Disease. Kidney International, 60, 324-332.
- Nigwekar, S.U., Thadhnadi, R. and Branderburg, V.M. (2018) Calciphylaxis. The New England Journal of Medicine, 378, 1704-1714. https://doi.org/10.1056/NEJMra1505292